Results 181 to 190 of about 106,421 (289)

Volume kinetics of lactated Ringer's solution in adult horses

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Fluid therapy in horses is primarily empirical. Evidence‐based quantification of the disposition of intravenous (IV) crystalloids used in clinical practice could enhance the effectiveness of fluid therapy. Objectives To determine the pharmacokinetics (i.e., volume kinetics: VK) and associated haemodynamic effects of IV lactated ...
William W. Muir   +3 more
wiley   +1 more source

Urine culture and urinalysis utilization practices in United States acute care hospitals between 2017 and 2020. [PDF]

open access: yesInfect Control Hosp Epidemiol
Asonganyi NL   +6 more
europepmc   +1 more source

439 The Impact of Urinalysis Turnaround Times on Patient Disposition in an Emergency Department Setting [PDF]

open access: bronze
Patricia Hernández   +6 more
openalex   +1 more source

Interference of Herbal Drinks with Urinalysis for Drugs of Abuse [PDF]

open access: bronze, 1993
Charles L. Winek   +3 more
openalex   +1 more source

Urinalysis Using a Diaper-Based Testing Device [PDF]

open access: gold, 2020
Wei-Hsuan Sung   +6 more
openalex   +1 more source

Outbreak of poisoning by sodium hydrogen methylarsonate (MSMA)—an arsenic‐based herbicide—in horses in Brazil

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Arsenic poisoning in horses is rarely reported in the literature. However, arsenic compounds can be present in rodenticides, pesticides, and herbicides, representing a potential source of accidental exposure for horses. Objective To describe the epidemiological, clinical, and laboratory findings from a herd of 31 horses exposed to ...
Gabriella Faria Pereira   +7 more
wiley   +1 more source

Evaluation of urinalysis parameters and antimicrobial susceptibility of uropathogens among out-patients at University of Cape Coast hospital

open access: diamond, 2019
James Kojo Prah   +5 more
openalex   +2 more sources

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy